Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics
- PMID: 19022512
- DOI: 10.1016/j.tibtech.2008.10.006
Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics
Abstract
The successful treatment of cancer with conventional drugs is frequently complicated by the resistance of tumor cells to such a non-specific therapy. Over the last few years, immunotherapy has gained attention as a tumor-specific approach. Recent findings demonstrated that some conventional cytostatics stimulate local anticancer responses. New anticancer drugs, including their polymeric derivatives, are currently being developed with the aim of destroying tumors more effectively and more specifically. Among these, the water-soluble conjugates of doxorubicin with N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier have emerged as efficient therapeutics because they are able to not only directly destroy cancer cells but also elicit systemic tumor-specific anticancer responses. Here, we discuss new insights into their mechanisms of immune surveillance, which could suggest novel approaches to cancer therapy.
Similar articles
-
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S189-99. doi: 10.1677/erc.1.01045. Endocr Relat Cancer. 2005. PMID: 16113096 Review.
-
Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.J Control Release. 2005 Dec 10;110(1):119-29. doi: 10.1016/j.jconrel.2005.09.028. Epub 2005 Nov 2. J Control Release. 2005. PMID: 16269198
-
A new classification system of anticancer drugs - based on cell biological mechanisms.Med Hypotheses. 2006;66(5):883-7. doi: 10.1016/j.mehy.2005.11.036. Epub 2006 Jan 18. Med Hypotheses. 2006. PMID: 16414204
-
Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer.Med Hypotheses. 2000 Oct;55(4):330-4. doi: 10.1054/mehy.2000.1063. Med Hypotheses. 2000. PMID: 11000062
-
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.Eur J Pharm Biopharm. 2009 Mar;71(3):409-19. doi: 10.1016/j.ejpb.2008.11.010. Epub 2008 Dec 3. Eur J Pharm Biopharm. 2009. PMID: 19070661 Review.
Cited by
-
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.Crit Rev Oncol Hematol. 2013 Jun;86(3):232-50. doi: 10.1016/j.critrevonc.2012.09.014. Epub 2012 Oct 23. Crit Rev Oncol Hematol. 2013. PMID: 23098684 Free PMC article. Review.
-
Polymer-drug conjugates: origins, progress to date and future directions.Adv Drug Deliv Rev. 2013 Jan;65(1):49-59. doi: 10.1016/j.addr.2012.10.014. Epub 2012 Nov 2. Adv Drug Deliv Rev. 2013. PMID: 23123294 Free PMC article. Review.
-
Immune-enhancing effect of water-soluble beta-glucan derived from enzymatic hydrolysis of yeast glucan.Biochem Biophys Rep. 2022 Mar 27;30:101256. doi: 10.1016/j.bbrep.2022.101256. eCollection 2022 Jul. Biochem Biophys Rep. 2022. PMID: 35368741 Free PMC article.
-
HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours.Biomaterials. 2020 Mar;235:119728. doi: 10.1016/j.biomaterials.2019.119728. Epub 2019 Dec 26. Biomaterials. 2020. PMID: 32044514 Free PMC article.
-
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy.Pharmaceutics. 2021 Jan 28;13(2):179. doi: 10.3390/pharmaceutics13020179. Pharmaceutics. 2021. PMID: 33525658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
